DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.

Bioinspired Biomimetic and Nanobiomaterials is a distinguished journal published by Emerald Group Publishing Ltd, focusing on the cutting-edge intersection of biomaterials, engineering, and nanotechnology. Since its inception in 2012, the journal has provided a vital platform for researchers, professionals, and students to disseminate innovative findings that draw inspiration from nature to develop novel biomimetic and bioinspired materials. Although currently indexed in the fourth quartile for Biomaterials and third quartile for miscellaneous Engineering in 2023, the journal is committed to improving its standing and impact by welcoming contributions that exploit the functional capabilities of nanoscale and biomimetic structures. With a strategic aim to foster interdisciplinary collaboration, this journal plays an instrumental role in advancing the field of biomaterials and engineering. Join our community and contribute to shaping the future of sustainable material design and applications.

Nanomaterials and Nanotechnology is a premier journal published by HINDAWI LTD, dedicated to advancing knowledge in the rapidly evolving fields of nanomaterials and nanoscale applications. Established as an Open Access platform since 2011, the journal aims to disseminate high-quality research that provides insights into nanotechnology's manifold aspects, including biotechnology, ceramics and composites, as well as electrical and electronic engineering. With a compelling impact factor reflected in its robust Scopus rankings—placing it in the 80th percentile in Engineering and the 72nd percentile in Biotechnology—it stands as a key resource for researchers, professionals, and students seeking to stay at the forefront of innovation in materials science. The journal occupies a distinguished position in the academic community, featuring studies that explore the synthesis, characterization, and application of nanomaterials, thereby contributing significantly to scientific discourse and technological advancement in this critical area.

JOURNAL OF NANOPARTICLE RESEARCH, published by SPRINGER, is a pivotal platform in the interdisciplinary field of nanotechnology, encompassing atomic and molecular physics, bioengineering, chemistry, condensed matter physics, and materials science. Operating since 1999 and converging through 2024, this journal presents cutting-edge research and innovations in nanoparticle science, aiming to bridge theoretical studies with practical applications. With a diverse scope that attracts articles ranked in various Q2 and Q3 category quartiles across its fields, including Bioengineering and Nanoscience and Nanotechnology, it ranks favorably within Scopus metrics, ensuring high visibility and impact among researchers. While the journal operates under traditional access models, it remains a critical resource for professionals and students alike, empowering them to advance their knowledge and drive future discoveries in this rapidly evolving area of study.

MOLECULES, published by MDPI, stands as a prominent open-access journal dedicated to the field of chemistry, with an exceptional reputation in various sub-disciplines. Since its inception in 1997, this journal has committed itself to the dissemination of innovative research, spanning topics in Analytical Chemistry, Organic Chemistry, Pharmaceutical Science, and Drug Discovery. With impressive rankings across Scopus categories—including a coveted Q1 designation in both Analytical Chemistry and Pharmaceutical Science—MOLECULES is recognized as a vital resource for researchers, professionals, and students aiming to stay at the forefront of scientific development. The journal’s data reflect its wide-ranging influence, holding high percentiles in multiple chemistry categories, thereby ensuring that its articles reach a significant audience. As an open-access journal, it provides unparalleled access to its content, available freely and globally, which promotes further advancement and collaboration within the scientific community. Its ongoing commitment to high-quality research from 1996 to 2024 reinforces its status as a leader in the academic publishing landscape.

The Journal of Experimental Nanoscience, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing the field of nanoscience and its applications across various disciplines. Since its establishment, the journal has aimed to provide a comprehensive platform for researchers and professionals to disseminate innovative findings in nanotechnology, bioengineering, and materials science. With an ISSN of 1745-8080 and E-ISSN of 1745-8099, this journal has been pivotal in promoting high-quality research in its converged years from 2006 to 2024. Recognized for its contributions, it currently holds a Q3 ranking in core categories such as Bioengineering, Biomedical Engineering, Materials Science, and Nanoscience and Nanotechnology. Although its H-index is not specified, its Scopus ranks reflect its growing influence, with notable percentiles in various engineering fields. By offering open access since 2016, the Journal of Experimental Nanoscience enhances the accessibility of vital research to a global audience. Researchers, professionals, and students will find this journal an invaluable resource for staying abreast of the latest advancements and breakthroughs in nanoscience.

MATERIALS TECHNOLOGY is a prestigious academic journal published by Taylor & Francis Ltd, based in the United Kingdom. With an ISSN of 1066-7857 and an E-ISSN of 1753-5557, this journal has established itself as a vital resource in the fields of Condensed Matter Physics, Materials Science, Mechanical Engineering, and Mechanics of Materials, earning a Q2 ranking in multiple categories as of 2023. With a rich publication history that dates back to the early 1970s, it serves as an essential platform for disseminating innovative research and developments in materials technology. Although not available through Open Access, the journal continues to attract contributions from leading researchers, ensuring high-quality articles that advance knowledge in the materials domain. The journal's commitment to excellence is reflected in its notable Scopus rankings, placing it within the 70th to 78th percentiles across several engineering and physics categories. As a vital resource for researchers, professionals, and students alike, MATERIALS TECHNOLOGY plays a critical role in shaping the future of materials science and engineering.

Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.

BioNanoScience is an esteemed academic journal published by SPRINGER, dedicated to the interdisciplinary field of bioengineering and biomedical engineering. With an ISSN of 2191-1630 and an E-ISSN of 2191-1649, the journal has established itself as a significant platform for sharing innovative research and developments in nanotechnology as applied to biomedical contexts. Although it operates under a subscription model, the journal maintains a strong impact within its field, achieving a Q3 quartile ranking in both categories for 2023 and has a solid standing in Scopus rankings, where it ranks #129 out of 303 in Biomedical Engineering and #87 out of 162 in Bioengineering. The journal not only aims to publish high-quality research, but also seeks to foster collaboration between scientists, engineers, and healthcare professionals to address pressing global health challenges through nanotechnology. As an essential resource for researchers, professionals, and students, BioNanoScience continues to contribute to the advancement of knowledge and innovation in bioengineering.

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.